AEGERION PHARMACEUTICALS INC's ticker is AEGR and the CUSIP is 00767E102. A total of 97 filers reported holding AEGERION PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 1.68 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $5,097,000 | +149.7% | 1,716,200 | +25.3% | 0.01% | +125.0% |
| Q2 2016 | $2,041,000 | -29.0% | 1,369,500 | +76.4% | 0.00% | -20.0% |
| Q1 2016 | $2,873,000 | +125.9% | 776,429 | +516.7% | 0.01% | +66.7% |
| Q4 2015 | $1,272,000 | -59.8% | 125,900 | -45.9% | 0.00% | -62.5% |
| Q3 2015 | $3,166,000 | +4.6% | 232,800 | +45.9% | 0.01% | +14.3% |
| Q2 2015 | $3,027,000 | +1.9% | 159,575 | +79.3% | 0.01% | -12.5% |
| Q3 2014 | $2,971,000 | +21.0% | 89,000 | +16.3% | 0.01% | +33.3% |
| Q2 2014 | $2,455,000 | -45.8% | 76,500 | +44.9% | 0.01% | -45.5% |
| Q3 2013 | $4,528,000 | – | 52,800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADVENT INTERNATIONAL, L.P. | 372,001 | $7,790,000 | 6.22% |
| Broadfin Capital, LLC | 5,097,726 | $106,746,000 | 4.64% |
| ARMISTICE CAPITAL, LLC | 372,000 | $7,790,000 | 3.74% |
| SCOPIA CAPITAL MANAGEMENT LP | 5,349,840 | $112,026,000 | 2.09% |
| SPHERA FUNDS MANAGEMENT LTD. | 160,000 | $3,350,000 | 0.57% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 2,755,933 | $57,709,000 | 0.34% |
| NORTH TIDE CAPITAL, LLC | 200,000 | $4,188,000 | 0.28% |
| Broadfin Capital, LLC | 300,000 | $6,282,000 | 0.27% |
| Point72 Asset Management, L.P. | 1,854,600 | $38,835,000 | 0.27% |
| PointState Capital LP | 600,000 | $12,564,000 | 0.21% |